Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/9171| Title: | A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia | Authors: | Vormoor, B. Veal, G. J. Griffin, M. J. Boddy, A. V. Irving, J. Minto, L. Case, M. Banerji, U. Swales, K. E. Tall, J. R. Moore, A. S. Toguchi, M. Acton, G. Dyer, K. Schwab, C. Harrison, C. J. Grainger, J. D. Lancaster, D. Kearns, P. Hargrave, D. Vormoor, J. |
Issue Date: | 2016 | Journal: | Pediatr Blood Cancer |
| Appears in Sites: | Publication workflow Queensland Health Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.